
Equine Pharmaceuticals & Supplements Market by Product (Pharmaceutical, Supplement), Distribution Channel (Drug Stores, Veterinary Hospitals) - Global Forecast 2024-2030
Description
Equine Pharmaceuticals & Supplements Market by Product (Pharmaceutical, Supplement), Distribution Channel (Drug Stores, Veterinary Hospitals) - Global Forecast 2024-2030
The Equine Pharmaceuticals & Supplements Market size was estimated at USD 930.52 million in 2023 and expected to reach USD 983.49 million in 2024, at a CAGR 5.78% to reach USD 1,379.52 million by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Equine Pharmaceuticals & Supplements Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Equine Pharmaceuticals & Supplements Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Equine Pharmaceuticals & Supplements Market, highlighting leading vendors and their innovative profiles. These include Alltech, Bayer AG, Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Sante Animale, Dechra Veterinary Products Limited, Elanco Animal Health Incorporated, Equineproducts-uk Ltd., Lallemand, Inc., Merck & Co., Inc., Purina Animal Nutrition LLC, Thermo Fisher Scientific Inc., Vetoquinol USA, Virbac, and Zoetis Inc..
Market Segmentation & Coverage
This research report categorizes the Equine Pharmaceuticals & Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Pharmaceutical
Anti-Inflammatory
Anti-Ulcer Drugs
Sedative & Tranquilizer
Supplement
Joint Supplements
Vitamins & Minerals
Distribution Channel
Drug Stores
Veterinary Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Equine Pharmaceuticals & Supplements Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Equine Pharmaceuticals & Supplements Market?
3. What are the technology trends and regulatory frameworks in the Equine Pharmaceuticals & Supplements Market?
4. What is the market share of the leading vendors in the Equine Pharmaceuticals & Supplements Market?
5. Which modes and strategic moves are suitable for entering the Equine Pharmaceuticals & Supplements Market?PDF E-mail From Publisher (2-5)Users License
Table of Contents
182 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Equine Pharmaceuticals & Supplements Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing awareness about equine pharmaceuticals and supplements products
- 5.1.1.2. Rising demand for herbal feed, digestive, and energy supplements owing to the choice among horse breeders for organic products
- 5.1.1.3. Growing adoption of equine supplements in horse racing and equestrian sectors
- 5.1.2. Restraints
- 5.1.2.1. Stringent regulations regarding the pharmaceutical products and supplements
- 5.1.3. Opportunities
- 5.1.3.1. Growing emphasis on overall equine health and wellness, and extensively use of electrolyte supplements
- 5.1.3.2. Development of new equine pharmaceuticals & supplements
- 5.1.4. Challenges
- 5.1.4.1. Side effects on the health of equine
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Equine Pharmaceuticals & Supplements Market, by Product
- 6.1. Introduction
- 6.2. Pharmaceutical
- 6.3.1. Anti-Inflammatory
- 6.3.2. Anti-Ulcer Drugs
- 6.3.3. Sedative & Tranquilizer
- 6.3. Supplement
- 6.4.1. Joint Supplements
- 6.4.2. Vitamins & Minerals
- 7. Equine Pharmaceuticals & Supplements Market, by Distribution Channel
- 7.1. Introduction
- 7.2. Drug Stores
- 7.3. Veterinary Hospitals
- 8. Americas Equine Pharmaceuticals & Supplements Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Equine Pharmaceuticals & Supplements Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Equine Pharmaceuticals & Supplements Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Alltech
- 12.1.2. Bayer AG
- 12.1.3. Boehringer Ingelheim International GmbH
- 12.1.4. Cargill, Incorporated
- 12.1.5. Ceva Sante Animale
- 12.1.6. Dechra Veterinary Products Limited
- 12.1.7. Elanco Animal Health Incorporated
- 12.1.8. Equineproducts-uk Ltd.
- 12.1.9. Lallemand, Inc.
- 12.1.10. Merck & Co., Inc.
- 12.1.11. Purina Animal Nutrition LLC
- 12.1.12. Thermo Fisher Scientific Inc.
- 12.1.13. Vetoquinol USA
- 12.1.14. Virbac
- 12.1.15. Zoetis Inc.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET RESEARCH PROCESS
- FIGURE 2. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2023 VS 2030
- FIGURE 3. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET DYNAMICS
- FIGURE 7. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
- FIGURE 10. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. EQUINE PHARMACEUTICALS & SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.